Medtronic Debt-to-Assets Ratio Growth & History (MDT)
Medtronic's debt-to-assets ratio was 0.29 for fiscal 2026.
View full Medtronic company overviewMedtronic annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | 0.29 | 0.00 | +0.80% |
| 2025 | 2025-04-25 | 0.29 | 0.00 | +0.87% |
| 2024 | 2024-04-26 | 0.29 | 0.01 | +3.61% |
| 2023 | 2023-04-28 | 0.28 | 0.05 | +19.58% |
| 2022 | 2022-04-29 | 0.23 | −0.06 | −20.66% |
| 2021 | 2021-04-30 | 0.29 | 0.01 | +3.00% |
| 2020 | 2020-04-24 | 0.29 | 0.00 | +0.87% |
| 2019 | 2019-04-26 | 0.28 | 0.00 | +0.53% |
| 2018 | 2018-04-27 | 0.28 | −0.05 | −15.75% |
| 2017 | 2017-04-28 | 0.33 | 0.02 | +7.71% |
| 2016 | 2016-04-29 | 0.31 | −0.02 | −6.97% |
| 2015 | 2015-04-24 | 0.33 | 0.06 | +22.76% |
| 2014 | 2014-04-25 | 0.27 | — | — |
Medtronic quarterly debt-to-assets ratio
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | 0.27 | −0.01 | −4.59% |
| Q4 2026 | 2026-04-24 | 0.29 | 0.00 | +0.80% |
| Q3 2026 | 2026-01-31 | 0.31 | 0.04 | +15.10% |
| Q3 2026 | 2026-01-23 | 0.30 | 0.04 | +14.32% |
| Q2 2026 | 2025-10-24 | 0.30 | 0.03 | +10.88% |
| Q1 2026 | 2025-07-25 | 0.29 | −0.01 | −1.84% |
| Q4 2025 | 2025-04-25 | 0.29 | 0.00 | +0.87% |
| Q3 2025 | 2025-01-24 | 0.27 | 0.00 | +0.26% |
| Q2 2025 | 2024-10-25 | 0.27 | 0.01 | +3.70% |
| Q1 2025 | 2024-07-26 | 0.29 | 0.02 | +8.79% |
| Q4 2024 | 2024-04-26 | 0.29 | 0.01 | +3.61% |
| Q3 2024 | 2024-01-26 | 0.27 | 0.03 | +12.70% |
| Q2 2024 | 2023-10-27 | 0.26 | 0.04 | +18.40% |
| Q1 2024 | 2023-07-28 | 0.27 | 0.08 | +38.61% |
| Q4 2023 | 2023-04-28 | 0.28 | 0.05 | +19.58% |
| Q3 2023 | 2023-01-27 | 0.24 | −0.03 | −10.83% |
| Q2 2023 | 2022-10-28 | 0.22 | −0.06 | −20.25% |
| Q1 2023 | 2022-07-29 | 0.19 | −0.09 | −31.24% |
| Q4 2022 | 2022-04-29 | 0.23 | −0.06 | −20.66% |
| Q3 2022 | 2022-01-28 | 0.26 | −0.01 | −2.89% |
| Q2 2022 | 2021-10-29 | 0.28 | 0.01 | +3.05% |
| Q1 2022 | 2021-07-30 | 0.28 | 0.04 | +16.12% |
| Q4 2021 | 2021-04-30 | 0.29 | 0.01 | +3.00% |
| Q3 2021 | 2021-01-29 | 0.27 | −0.00 | −1.79% |
| Q2 2021 | 2020-10-30 | 0.27 | −0.01 | −4.28% |
| Q1 2021 | 2020-07-31 | 0.24 | −0.04 | −13.80% |
| Q4 2020 | 2020-04-24 | 0.29 | 0.00 | +0.87% |
| Q3 2020 | 2020-01-24 | 0.28 | 0.01 | +3.98% |
| Q2 2020 | 2019-10-25 | 0.28 | 0.01 | +5.35% |
| Q1 2020 | 2019-07-26 | 0.28 | 0.02 | +7.04% |
| Q4 2019 | 2019-04-26 | 0.28 | 0.00 | +0.53% |
| Q3 2019 | 2019-01-25 | 0.27 | −0.00 | −1.38% |
| Q2 2019 | 2018-10-26 | 0.27 | −0.01 | −2.21% |
| Q1 2019 | 2018-07-27 | 0.26 | 0.01 | +1.94% |
| Q4 2018 | 2018-04-27 | 0.28 | −0.05 | −15.75% |
| Q3 2018 | 2018-01-26 | 0.27 | 0.00 | +1.84% |
| Q2 2018 | 2017-10-27 | 0.27 | −0.02 | −6.84% |
| Q1 2018 | 2017-07-28 | 0.26 | −0.05 | −15.26% |
| Q4 2017 | 2017-04-28 | 0.33 | 0.02 | +7.71% |
| Q3 2017 | 2017-01-27 | 0.27 | −0.06 | −18.99% |
| Q2 2017 | 2016-10-28 | 0.29 | −0.03 | −8.17% |
| Q1 2017 | 2016-07-29 | 0.31 | −0.02 | −5.17% |
| Q4 2016 | 2016-04-29 | 0.31 | −0.02 | −6.97% |
| Q3 2016 | 2016-01-29 | 0.33 | — | — |
| Q2 2016 | 2015-10-30 | 0.32 | — | — |
| Q1 2016 | 2015-07-31 | 0.32 | — | — |
| Q4 2015 | 2015-04-24 | 0.33 | 0.06 | +22.76% |
| Q4 2014 | 2014-04-25 | 0.27 | — | — |
Medtronic debt-to-assets ratio trends
Over the last five fiscal years, Medtronic's debt-to-assets ratio decreased from 0.29 to 0.29, a change of −0.00. The latest reported quarter, Q1 2027, shows 0.27.
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...